Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2012
02/16/2012US20120041414 Medication delivery system and monitor
02/16/2012US20120041357 Method of controlled drug release from a liposome carrier
02/16/2012US20120041355 Multiple section parenteral drug delivery apparatus
02/16/2012US20120041067 Methods of Inducing Terminal Differentiation
02/16/2012US20120041034 Sustained release aminopyridine composition
02/16/2012US20120041021 Process for Preparing a Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
02/16/2012US20120041020 Methods of Treatment Utilizing Semi-Solid Pharmaceutical Compositions
02/16/2012US20120040901 Novel biomaterials, their preparation and use
02/16/2012US20120040829 Bacterial ghosts as carrier and targeting vehicles
02/16/2012US20120040011 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
02/16/2012US20120040010 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
02/16/2012US20120040009 Particulate pharmaceutical composition with an opioid and an opioid antagonist
02/16/2012US20120040008 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012US20120040007 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa
02/16/2012US20120040006 Pharmaceutical Compositions Comprising Brivaracetam
02/16/2012US20120040004 Treatment of radiation-induced fibrosis
02/16/2012US20120040003 Anti-dandruff compositions with citrus fibers
02/16/2012US20120040002 Resorbable and biocompatible fibre glass compositions and their uses
02/16/2012US20120040001 Disintegrating particle composition and rapidly disintegrating compression-molded material used the same
02/16/2012US20120040000 Peptide pharmaceutical for oral delivery
02/16/2012US20120039999 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012US20120039998 Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
02/16/2012US20120039997 Methods of treating hypertriglyceridemia
02/16/2012US20120039996 Uses of red yeast rice in treating dengue virus infection
02/16/2012US20120039995 Arsenic compounds, their preparation methods and uses thereof
02/16/2012US20120039994 Vaccine composition containing synthetic adjuvant
02/16/2012US20120039993 Detection of Gene Expression
02/16/2012US20120039992 Compositions of polymeric myrcene
02/16/2012US20120039991 Use of apoptosis inhibiting compounds in degenerative neurological disorders
02/16/2012US20120039990 Liposome Compositions and Methods of Use Thereof
02/16/2012US20120039989 Erythrocyte-binding therapeutics
02/16/2012US20120039988 Cancer-targeting peptides and uses thereof in cancer therapy
02/16/2012US20120039987 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039985 Dendritic cell modulation in post-ischemic wounds
02/16/2012US20120039984 Glycopeptide and uses thereof
02/16/2012US20120039983 Amphiphilic macromolecule-lipid complexes
02/16/2012US20120039982 Bio-Sheet for Eye Tissue Repair
02/16/2012US20120039981 Chewing Gum And Particulate Material For Controlled Release Of Active Ingredients
02/16/2012US20120039980 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
02/16/2012US20120039978 Novel Anti-Viral Method
02/16/2012US20120039975 Nanocomposite materials having electromagnetic-radiation barrier properties and process for obtainment thereof
02/16/2012US20120039970 Ready-to-use, stable suspension of partially amorphous carotenoid particles
02/16/2012US20120039969 Swellable dosage form comprising gellan gum
02/16/2012US20120039965 Enhanced antimicrobial activity compositions of blends of plant essential oils
02/16/2012US20120039964 Novel formulations of fat-soluble active ingredients with high bioavailability
02/16/2012US20120039963 3-(2-Dimethlaminomethyl Cyclohexyl)Phenol Retard Formulation
02/16/2012US20120039962 Pharmaceutical Compositions
02/16/2012US20120039961 Implant and therapeutic composition for treating damage and/or diseases relating to the human animal musculoskeletal system
02/16/2012US20120039960 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
02/16/2012US20120039959 Anti-Adhesion Alginate Barrier of Variable Absorbance
02/16/2012US20120039958 Compositions and methods for treatment of taupathy
02/16/2012US20120039957 Optimized niacin compositions in pharmaceutical products
02/16/2012US20120039956 Dry storage stabilizing composition for biological materials
02/16/2012US20120039955 Treatment of Diabetes with Pancreatic Endocrine Precursor Cells
02/16/2012US20120039954 Method of treating insomnia
02/16/2012US20120039953 Riluzole aqueous suspensions
02/16/2012US20120039952 Compositions, methods & systems for respiratory delivery of two or more active agents
02/16/2012US20120039951 Compositions and methods for enhancing physiological performance and recovery time
02/16/2012US20120039950 Colostrum composition
02/16/2012US20120039949 Stable Solid Formulations of GC-C Receptor Agonist Polypeptides Suitable for Oral Administration
02/16/2012US20120039948 Instant Vesicular Product
02/16/2012US20120039947 Methods and compositions for treating psoriasis
02/16/2012US20120039876 Stabilized liquid anti-rsv antibody formulations
02/16/2012US20120039818 Anti-chafing aerosol powder
02/16/2012US20120039817 Compositions, methods & systems for respiratory delivery of two or more active agents
02/16/2012US20120039814 Topical Compositions and Methods of Detection and Treatment
02/16/2012US20120039806 Compounds and Methods for Modulating an Immune Response
02/16/2012US20120039799 Viral nanoparticle cell-targeted delivery platform
02/16/2012US20120039796 Novel method for creating, suspending and stabilizing electronically modified oxygen derivatives, along with creating, suspending and stabilizing electronically modified reaction intermediates, in a bio compatible fluorocarbon suspension, for the purpose of inducing a cascading immune response in mammalian patients
02/16/2012US20120038073 Spray drying methods and related compositions
02/16/2012DE102004045186B9 Liposomen, die die intrazelluläre Penetration von Wirkstoffen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of active substances, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration
02/16/2012CA2844474A1 Probiotic liquid food products
02/16/2012CA2808313A1 Liposome compositions and methods of use thereof
02/16/2012CA2808091A1 Stable formulations of linaclotide
02/16/2012CA2807942A1 Erythrocyte-binding therapeutics
02/16/2012CA2807806A1 Oral compositions comprising a zinc compound and an anti-microbial agent
02/16/2012CA2807723A1 Foamable compositions of stabilized chlorite
02/16/2012CA2807206A1 Formulations for infusion of type b lantibiotics
02/16/2012CA2806459A1 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/16/2012CA2805974A1 Use of binders for manufacturing storage stable formulations
02/16/2012CA2804749A1 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
02/15/2012EP2418208A1 Inhibitor for elevation of gip level
02/15/2012EP2417982A1 Stabilization of gonadotropins
02/15/2012EP2417979A1 Beneficial effects of increasing local blood flow
02/15/2012EP2417978A1 Beneficial effects of increasing local blood flow
02/15/2012EP2417977A1 Calcium carbonate granulation
02/15/2012EP2417975A1 Fulvestrant nanosphere/microsphere and preparative method and use thereof
02/15/2012EP2417973A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO Ý4, 3-b¨INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE
02/15/2012EP2417970A2 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles
02/15/2012EP2417969A1 Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
02/15/2012EP2417968A1 Particle comprising cytokines, antibodies and polymers and use thereof as medicament for the treatment of cancer
02/15/2012EP2417967A1 A transmucosal composition containing anthocyanins for alleviating a visual discomfort
02/15/2012EP2417943A1 Drug-delivery endovascular stent and method for treating restenosis
02/15/2012EP2417258A1 Bacteriophage compositions for treatment of bacterial infections
02/15/2012EP2417106A1 Process for preparing pyrrolidinium salts
02/15/2012EP2416834A1 Modular ingestible drug delivery capsule
02/15/2012EP2416799A2 Par-1 activation by metalloproteinase-1 (mmp-1)
02/15/2012EP2416777A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
02/15/2012EP2416775A1 Active pharmaceutical ingredient adsorbed on solid support
1 ... 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 ... 2991